Radiotherapy for nasopharyngeal cancer

P. Blanchard; J. Biau; F. Huguet; S. Racadot; C. Berthold; S. Wong-Hee-Kam; M. C. Biston; P. Maingon

doi:10.1016/j.canrad.2021.08.009

Radiotherapy for nasopharyngeal cancer

Titre traduit de la contribution: Radiothérapie du cancer du nasopharynx

P. Blanchard, J. Biau, F. Huguet, S. Racadot, C. Berthold, S. Wong-Hee-Kam, M. C. Biston, P. Maingon

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

8 Citations (Scopus)

Résumé

Nasopharyngeal cancers are a rarity in France. Radiotherapy is the cornerstone of treatment, frequently combined with chemotherapy. The technical modality of radiotherapy is complex in this disease, which is located in the vicinity of numerous organs at risk. In this article, we will present the updated guidelines of the French society for radiation oncology (Société française de radiothérapie oncologique, SFRO) on the indications, and technical details of radiotherapy in nasopharyngeal cancers.

Titre traduit de la contribution	Radiothérapie du cancer du nasopharynx
langue originale	Anglais
Pages (de - à)	168-173
Nombre de pages	6
journal	Cancer/Radiotherapie
Volume	26
Numéro de publication	1-2
Les DOIs	https://doi.org/10.1016/j.canrad.2021.08.009
état	Publié - 1 févr. 2022

Accès au document

10.1016/j.canrad.2021.08.009

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{3127614fb9b441e8bc56cfd4e6d25d0c,

title = "Radiotherapy for nasopharyngeal cancer",

abstract = "Nasopharyngeal cancers are a rarity in France. Radiotherapy is the cornerstone of treatment, frequently combined with chemotherapy. The technical modality of radiotherapy is complex in this disease, which is located in the vicinity of numerous organs at risk. In this article, we will present the updated guidelines of the French society for radiation oncology (Soci{\'e}t{\'e} fran{\c c}aise de radioth{\'e}rapie oncologique, SFRO) on the indications, and technical details of radiotherapy in nasopharyngeal cancers.",

keywords = "Chemotherapy, Guidelines, Nasopharyngeal cancer, Radiotherapy, Soci{\'e}t{\'e} fran{\c c}aise de radioth{\'e}rapie oncologique",

author = "P. Blanchard and J. Biau and F. Huguet and S. Racadot and C. Berthold and S. Wong-Hee-Kam and Biston, {M. C.} and P. Maingon",

note = "Publisher Copyright: {\textcopyright} 2021 Soci{\'e}t{\'e} fran{\c c}aise de radioth{\'e}rapie oncologique (SFRO)",

year = "2022",

month = feb,

day = "1",

doi = "10.1016/j.canrad.2021.08.009",

language = "English",

volume = "26",

pages = "168--173",

journal = "Cancer/Radiotherapie",

issn = "1278-3218",

number = "1-2",

}

TY - JOUR

T1 - Radiotherapy for nasopharyngeal cancer

AU - Blanchard, P.

AU - Biau, J.

AU - Huguet, F.

AU - Racadot, S.

AU - Berthold, C.

AU - Wong-Hee-Kam, S.

AU - Biston, M. C.

AU - Maingon, P.

PY - 2022/2/1

Y1 - 2022/2/1

N2 - Nasopharyngeal cancers are a rarity in France. Radiotherapy is the cornerstone of treatment, frequently combined with chemotherapy. The technical modality of radiotherapy is complex in this disease, which is located in the vicinity of numerous organs at risk. In this article, we will present the updated guidelines of the French society for radiation oncology (Société française de radiothérapie oncologique, SFRO) on the indications, and technical details of radiotherapy in nasopharyngeal cancers.

AB - Nasopharyngeal cancers are a rarity in France. Radiotherapy is the cornerstone of treatment, frequently combined with chemotherapy. The technical modality of radiotherapy is complex in this disease, which is located in the vicinity of numerous organs at risk. In this article, we will present the updated guidelines of the French society for radiation oncology (Société française de radiothérapie oncologique, SFRO) on the indications, and technical details of radiotherapy in nasopharyngeal cancers.

KW - Chemotherapy

KW - Guidelines

KW - Nasopharyngeal cancer

KW - Radiotherapy

KW - Société française de radiothérapie oncologique

UR - http://www.scopus.com/inward/record.url?scp=85124187090&partnerID=8YFLogxK

U2 - 10.1016/j.canrad.2021.08.009

DO - 10.1016/j.canrad.2021.08.009

M3 - Article

C2 - 34953699

AN - SCOPUS:85124187090

SN - 1278-3218

VL - 26

SP - 168

EP - 173

JO - Cancer/Radiotherapie

JF - Cancer/Radiotherapie

IS - 1-2

ER -